← board
PKTX
distress 5/10 · elevated risk$0.010%today-35% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.0 yrs
Shares 1y
+1%
Price & events
-1.5% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-22.9%
1W
+13.9%
1M
-7.8%
3M
-1.5%
6M
-20.0%
1Y
-54.6%
2Y
-95.1%
5Y
-93.6%
All
Overview
- Market Cap
- $2.51M
- Volume
- 0
- 52 Week Range
- $0.00 – $0.01
- Total Shares
- 391.58M
- Float Shares
- 323.67M
- % Held by Insiders
- 37.68%
- % Held by Institutions
- 0.01%
- Beta
- 0.76
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 391,580,152 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.